Usage of Omics Technology for Identification of Critical Mediators and Pathways in Patients with Hidradenitis Suppurativa
Latest Information Update: 09 Nov 2020
At a glance
- Drugs Adalimumab (Primary)
- Indications Hidradenitis suppurativa
- Focus Therapeutic Use
- Acronyms DERMMARK
- 08 Nov 2020 Status changed from recruiting to discontinued.
- 09 Apr 2019 New trial record